TGFB1 and neoplasm: Various ferroptotic inducers, including piperazine and pharmaceutical agents like sorafenib, statins, and sulfasalazine, along with cytokines such as IFN-γ and TGF-β1, have been demonstrated to induce ferroptosis in tumor cells, thus hindering tumor proliferation (Yang et al., 2014).